Back
4D Molecular Therapeutics Stock Predictions
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
11
FDMT
4D Molecular Therapeutics
Last Price:
11.61
Seasonality Move:
44.72%
7 Day Trial
ALL ACCESS PASS
$
7
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.4D Molecular Therapeutics Stock Forecast
- Over the next 52 weeks, 4D Molecular Therapeutics has on average historically risen by 2.4% based on the past 3 years of stock performance.
- 4D Molecular Therapeutics has risen higher in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is 4D Molecular Therapeutics Stock Undervalued?
The current 4D Molecular Therapeutics [FDMT] share price is $11.90. The Score for FDMT is 11, which is 78% below its historic median score of 50, and infers higher risk than normal. - FDMT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will 4D Molecular Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, 4D Molecular Therapeutics has on average historically risen by 2.4% based on the past 3 years of stock performance.
4D Molecular Therapeutics Stock Rating
Sell
11
4D Molecular Therapeutics (FDMT)
is a Sell
Is 4D Molecular Therapeutics overpriced?
- 4D Molecular Therapeutics has risen higher in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
4D Molecular Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
4dmoleculartherapeutics.com
52-Week Data
52-Week High:
36.25
52-Week Low:
9.44
Prediction Charts
Market Cap:
618.44M
Price in USD:
11.90
Volume:
1.74M
Beta:
2.85
Technical Analysis
SMA50:
16.36
SMA100:
20.22
SMA200:
22.25
52-Wk Change:
-17.93%
Stock Predictions
-
Is 4D Molecular Therapeutics stock public?
Yes, 4D Molecular Therapeutics is a publicly traded company. -
What is the 4D Molecular Therapeutics stock quote today?
The 4D Molecular Therapeutics stock price is 11.90 USD today. -
How to buy 4D Molecular Therapeutics stock online?
You can buy 4D Molecular Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Sep-3 | 14.90 | 14.76 | 15.56 | 14.57 |
| Sep-4 | 14.72 | 15.62 | 15.72 | 14.61 |
| Sep-5 | 15.71 | 15.50 | 15.71 | 15.22 |
| Sep-6 | 15.64 | 15.08 | 15.75 | 14.64 |
| Sep-9 | 15.06 | 15.27 | 15.51 | 14.92 |
| Sep-10 | 15.25 | 15.51 | 16.09 | 15.07 |
| Sep-11 | 15.34 | 15.71 | 15.75 | 15.01 |
| Sep-12 | 15.71 | 15.91 | 15.97 | 15.19 |
| Sep-13 | 16.02 | 16.25 | 16.59 | 16.02 |
| Sep-16 | 16.33 | 16.48 | 16.58 | 15.83 |
| Sep-17 | 16.60 | 16.16 | 16.82 | 16.14 |
| Sep-18 | 16.23 | 16.79 | 17.31 | 16.08 |
| Sep-19 | 17.39 | 13.50 | 17.41 | 12.48 |
| Sep-20 | 13.54 | 11.90 | 13.59 | 11.85 |
4D Molecular Therapeutics Earnings
4D Molecular Therapeutics Earnings Report: Per Share 4D Molecular Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
4D Molecular Therapeutics Forecast Revenue Growth
4D Molecular Therapeutics Stock Analysis: Historical quarterly revenues per share for 4D Molecular Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.23 per share, a decrease this year of $0.24 per share, and a decrease next year of $0.31 per share.
* 4D Molecular Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.